446 related articles for article (PubMed ID: 34884513)
1. Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions.
Sekeres MJ; Bradley-Garcia M; Martinez-Canabal A; Winocur G
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884513
[TBL] [Abstract][Full Text] [Related]
2. Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats.
Winocur G; Wojtowicz JM; Huang J; Tannock IF
Psychopharmacology (Berl); 2014 Jun; 231(11):2311-20. PubMed ID: 24343419
[TBL] [Abstract][Full Text] [Related]
3. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in the elucidation of the mechanisms of chemotherapy-induced cognitive impairment.
Alhowail AH; Aldubayan M
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5807-5817. PubMed ID: 34604972
[TBL] [Abstract][Full Text] [Related]
5. PAN-811 prevents chemotherapy-induced cognitive impairment and preserves neurogenesis in the hippocampus of adult rats.
Jiang ZG; Winocur G; Wojtowicz JM; Shevtsova O; Fuller S; Ghanbari HA
PLoS One; 2018; 13(1):e0191866. PubMed ID: 29370277
[TBL] [Abstract][Full Text] [Related]
6. Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits.
Orchard TS; Gaudier-Diaz MM; Weinhold KR; Courtney DeVries A
Breast Cancer Res Treat; 2017 Feb; 161(3):391-398. PubMed ID: 27933449
[TBL] [Abstract][Full Text] [Related]
7. BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis.
Usmani MT; Krattli RP; El-Khatib SM; Le ACD; Smith SM; Baulch JE; Ng DQ; Acharya MM; Chan A
Neurotherapeutics; 2023 Apr; 20(3):838-852. PubMed ID: 36720792
[TBL] [Abstract][Full Text] [Related]
8. The effect of systemic chemotherapy on neurogenesis, plasticity and memory.
Wigmore P
Curr Top Behav Neurosci; 2013; 15():211-40. PubMed ID: 23239468
[TBL] [Abstract][Full Text] [Related]
9. Melatonin attenuates 5-fluorouracil-induced spatial memory and hippocampal neurogenesis impairment in adult rats.
Sirichoat A; Suwannakot K; Chaisawang P; Pannangrong W; Aranarochana A; Wigmore P; Welbat JU
Life Sci; 2020 May; 248():117468. PubMed ID: 32105705
[TBL] [Abstract][Full Text] [Related]
10. Neural correlates of chemotherapy-related cognitive impairment.
Kaiser J; Bledowski C; Dietrich J
Cortex; 2014 May; 54():33-50. PubMed ID: 24632463
[TBL] [Abstract][Full Text] [Related]
11. Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain.
Park HS; Kim CJ; Kwak HB; No MH; Heo JW; Kim TW
Neuropharmacology; 2018 May; 133():451-461. PubMed ID: 29477301
[TBL] [Abstract][Full Text] [Related]
12. Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment.
Ntagwabira F; Trujillo M; McElroy T; Brown T; Simmons P; Sykes D; Allen AR
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216124
[TBL] [Abstract][Full Text] [Related]
13. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
[TBL] [Abstract][Full Text] [Related]
14. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
16. Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology.
Allegra A; Innao V; Basile G; Pugliese M; Allegra AG; Pulvirenti N; Musolino C
Expert Rev Hematol; 2020 Apr; 13(4):393-404. PubMed ID: 32129131
[No Abstract] [Full Text] [Related]
17. Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in rats.
Shaker FH; El-Derany MO; Wahdan SA; El-Demerdash E; El-Mesallamy HO
Life Sci; 2021 Mar; 269():119078. PubMed ID: 33460662
[TBL] [Abstract][Full Text] [Related]
18. Chemobrain: An accelerated aging process linking adenosine A
Oliveros A; Poleschuk M; Cole PD; Boison D; Jang MH
Int Rev Neurobiol; 2023; 170():267-305. PubMed ID: 37741694
[TBL] [Abstract][Full Text] [Related]
19. Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats.
Tong Y; Wang K; Sheng S; Cui J
Biosci Biotechnol Biochem; 2020 Jun; 84(6):1201-1210. PubMed ID: 31992173
[TBL] [Abstract][Full Text] [Related]
20. Memory loss in chemotherapy-treated rats is exacerbated in high-interference conditions and related to suppression of hippocampal neurogenesis.
Winocur G; Wojtowicz JM; Tannock IF
Behav Brain Res; 2015 Mar; 281():239-44. PubMed ID: 25529185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
